Open Date
-
Close Date
-
Listing Date
-
Price Range
₹0.0 to ₹0.0
IPO Size
₹0.00 Cr
Exchange Symbols
Curis Lifesciences Ltd
Cutoff - Lot Size
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Well Experienced Management Team.
Wide range of Products.
Strategic Location of Manufacturing Facility.
Scalable Business Model.
Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic on loan license and contract Manufacturing and Direct export basis. Our business is majorly on product to product basis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporate clients on loan license and contract manufacturing basis along with 2 clients for direct export globally for Republic of Yemen and Kenya. Our company has commenced manufacturing facility in year 2017, hence, our company has experience of more than 7 years in the current line of business of the company. Our manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. Our promoters have a vast experience in the pharmaceutical manufacturing Industry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical industry.
Company Name | Curis Lifesciences Ltd |
Headquarter | Ahmedabad |
info@curisls.com | |
Website | https://curisls.com |
MUFG Intime India Pvt Ltd
Phone Number | 91-22-49186000 |
Email ID | paytm.ipo@linkintime.co.in |
Website | www.linkintime.co.in |
Initial public issue of upto 22,50,000 equity shares of face value of Rs. 10/- each of Curis Lifesciences Limited ("Curis" or the "Company" or the "Issuer") for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share (the "Issue Price") aggregating to Rs. [*] crores ("The Issue"), of which [*] equity shares of face value of Rs. 10/- each for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share aggregating to Rs. [*] crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of [*] equity shares of face value of Rs. 10/- each at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share aggregating to Rs. [*] crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute [*] % and [*] %, respectively, of the post issue paid up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Address: PF-23 GIDC Sanand II, Industrial Estate, Ahmedabad, Gujarat, 382110
Phone: +91 70965 58558
Email: info@curisls.com
Website: https://curisls.com
Open Date: -
Close Date: -
Issue Price: ₹
Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Congratulations,
Your Digital savings bank account opening journey is complete.